Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model
Real world evidence (RWE) and real-world data (RWD) are drawing ever-increasing attention in the pharmaceutical industry and drug regulatory authorities (DRAs) all over the world due to their paramount role in supporting drug development and regulatory decision making. However, there is little syste...
Main Authors: | Meng Li, Shengqi Chen, Yunfeng Lai, Zuanji Liang, Jiaqi Wang, Junnan Shi, Haojie Lin, Dongning Yao, Hao Hu, Carolina Oi Lam Ung |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.669509/full |
Similar Items
-
Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications
by: Zou KH, et al.
Published: (2020-07-01) -
Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications
by: Zuanji Liang, et al.
Published: (2021-02-01) -
Real-World Evidence in Prescription Medication Use Among U.S. Adults with Neck Pain
by: Jin-Feng Huang, et al.
Published: (2020-09-01) -
Conducting real-world evidence studies in India
by: Arun Bhatt
Published: (2019-01-01) -
The Real-World Data Challenges Radar: A Review on the Challenges and Risks regarding the Use of Real-World Data
by: Frank Grimberg, et al.
Published: (2021-06-01)